Savant Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.6M | Sell |
28,355
-1,837
| -6% | -$242K | 0.01% | 475 |
|
|
2026
Q1 | $4.21M | Buy |
30,192
+3,108
| +11% | +$435K | 0.02% | 290 |
|
|
2025
Q4 | $3.32M | Buy |
27,084
+1,589
| +6% | +$193K | 0.02% | 310 |
|
|
2025
Q3 | $2.83M | Buy |
25,495
+860
| +3% | +$97.8K | 0.02% | 325 |
|
|
2025
Q2 | $2.73M | Buy |
24,635
+3,249
| +15% | +$346K | 0.02% | 306 |
|
|
2025
Q1 | $2.4M | Sell |
21,386
-6,535
| -23% | -$674K | 0.02% | 307 |
|
|
2024
Q4 | $2.58M | Buy |
27,921
+558
| +2% | +$50.2K | 0.02% | 378 |
|
|
2024
Q3 | $2.29M | Buy |
27,363
+4,077
| +18% | +$311K | 0.02% | 392 |
|
|
2024
Q2 | $1.6M | Sell |
23,286
-1,747
| -7% | -$117K | 0.02% | 447 |
|
|
2024
Q1 | $1.83M | Sell |
25,033
-717
| -3% | -$55.1K | 0.02% | 374 |
|
|
2023
Q4 | $2.09M | Sell |
25,750
-875
| -3% | -$68.1K | 0.03% | 281 |
|
|
2023
Q3 | $2M | Sell |
26,625
-151
| -0.6% | -$11.6K | 0.03% | 265 |
|
|
2023
Q2 | $2.06M | Buy |
26,776
+356
| +1% | +$28.4K | 0.03% | 253 |
|
|
2023
Q1 | $2.19M | Buy |
26,420
+1,203
| +5% | +$99.6K | 0.04% | 200 |
|
|
2022
Q4 | $849K | Buy |
25,217
+16,275
| +182% | +$1.29M | 0.02% | 280 |
|
|
2022
Q3 | $552K | Sell |
8,942
-226
| -2% | -$14.3K | 0.02% | 329 |
|
|
2022
Q2 | $567K | Buy |
9,168
+861
| +10% | +$53.3K | 0.02% | 324 |
|
|
2022
Q1 | $494K | Buy |
8,307
+481
| +6% | +$30.7K | 0.02% | 358 |
|
|
2021
Q4 | $569K | Buy |
7,826
+2,058
| +36% | +$142K | 0.02% | 332 |
|
|
2021
Q3 | $403K | Sell |
5,768
-327
| -5% | -$23K | 0.01% | 364 |
|
|
2021
Q2 | $420K | Sell |
6,095
-92
| -1% | -$6.14K | 0.02% | 341 |
|
|
2021
Q1 | $400K | Buy |
6,187
+93
| +2% | +$6K | 0.02% | 316 |
|
|
2020
Q4 | $355K | Sell |
6,094
-691
| -10% | -$41.7K | 0.02% | 325 |
|
|
2020
Q3 | $429K | Sell |
6,785
-373
| -5% | -$25.9K | 0.03% | 275 |
|
|
2020
Q2 | $551K | Buy |
7,158
+321
| +5% | +$24.6K | 0.04% | 230 |
|
|
2020
Q1 | $511K | Buy |
6,837
+1,009
| +17% | +$69.7K | 0.05% | 223 |
|
|
2019
Q4 | $379K | Buy |
5,828
+113
| +2% | +$7.36K | 0.05% | 244 |
|
|
2019
Q3 | $362K | Sell |
5,715
-140
| -2% | -$9.15K | 0.05% | 232 |
|
|
2019
Q2 | $396K | Sell |
5,855
-59
| -1% | -$3.88K | 0.06% | 217 |
|
|
2019
Q1 | $384K | Buy |
5,914
+227
| +4% | +$15.1K | 0.07% | 190 |
|
|
2018
Q4 | $356K | Sell |
5,687
-446
| -7% | -$31.2K | 0.07% | 177 |
|
|
2018
Q3 | $474K | Sell |
6,133
-31
| -0.5% | -$2.34K | 0.09% | 171 |
|
|
2018
Q2 | $437K | Sell |
6,164
-41
| -0.7% | -$2.9K | 0.09% | 163 |
|
|
2018
Q1 | $468K | Buy |
6,205
+108
| +2% | +$8.59K | 0.1% | 154 |
|
|
2017
Q4 | $437K | Buy |
6,097
+260
| +4% | +$19.7K | 0.09% | 167 |
|
|
2017
Q3 | $473K | Buy |
5,837
+47
| +0.8% | +$3.59K | 0.11% | 152 |
|
|
2017
Q2 | $410K | Buy |
5,790
+194
| +3% | +$12.9K | 0.1% | 160 |
|
|
2017
Q1 | $380K | Sell |
5,596
-2,019
| -27% | -$142K | 0.09% | 168 |
|
|
2016
Q4 | $545K | Sell |
7,615
-935
| -11% | -$69.5K | 0.15% | 116 |
|
|
2016
Q3 | $676K | Sell |
8,550
-304
| -3% | -$24.7K | 0.19% | 86 |
|
|
2016
Q2 | $739K | Sell |
8,854
-26
| -0.3% | -$2.31K | 0.21% | 80 |
|
|
2016
Q1 | $816K | Sell |
8,880
-600
| -6% | -$54.1K | 0.25% | 69 |
|
|
2015
Q4 | $959K | Buy |
9,480
+2,330
| +33% | +$242K | 0.3% | 55 |
|
|
2015
Q3 | $702K | Buy |
7,150
+481
| +7% | +$53.4K | 0.25% | 68 |
|
|
2015
Q2 | $781K | Sell |
6,669
-344
| -5% | -$37.6K | 0.26% | 68 |
|
|
2015
Q1 | $688K | Buy |
7,013
+389
| +6% | +$39.5K | 0.24% | 76 |
|
|
2014
Q4 | $624K | Buy |
6,624
+380
| +6% | +$39.3K | 0.24% | 76 |
|
|
2014
Q3 | $665K | Hold |
6,244
| – | – | 0.28% | 61 |
|
|
2014
Q2 | $518K | Sell |
6,244
-210
| -3% | -$16.3K | 0.22% | 81 |
|
|
2014
Q1 | $457K | Buy |
6,454
+56
| +0.9% | +$4.39K | 0.21% | 80 |
|
|
2013
Q4 | $480K | Buy |
6,398
+244
| +4% | +$17K | 0.24% | 70 |
|
|
2013
Q3 | $387K | Buy |
6,154
+470
| +8% | +$28.1K | 0.21% | 77 |
|
|
2013
Q2 | $291K | Buy |
+5,684
| New | +$296K | 0.17% | 98 |
|
Other funds holding GILD
Savant Capital's GILD Position: Q2 2026 in Review
Savant Capital reduced its Gilead Sciences (GILD) stake by 6.1% in Q2 2026, selling an estimated $242K and leaving 28,355 shares worth $3.6M. The position accounts for 0.01% of the portfolio, ranked #475.
Savant Capital first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.21M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Savant Capital held 28,355 shares of Gilead Sciences worth $3.6M as of Q2 2026.
- Savant Capital sold 1,837 Gilead Sciences shares in Q2 2026, an estimated $242K.
- Gilead Sciences made up 0.01% of Savant Capital's portfolio in Q2 2026, its #475 holding.
- Savant Capital first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- Savant Capital's Gilead Sciences position peaked at $4.21M in Q1 2026.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.